Found: 13
Select item for more details and to access through your institution.
WT1 peptide vaccine induces reduction in minimal residual disease in an Imatinib-treated CML patient.
- Published in:
- European Journal of Haematology, 2010, v. 85, n. 4, p. 358, doi. 10.1111/j.1600-0609.2010.01497.x
- By:
- Publication type:
- Article
A WT1 protein-derived, naturally processed 16-mer peptide, WT1<sub>332</sub>, is a promiscuous helper peptide for induction of WT1-specific Th1-type CD4<sup>+</sup> T cells.
- Published in:
- Microbiology & Immunology, 2008, v. 52, n. 12, p. 591, doi. 10.1111/j.1348-0421.2008.00080.x
- By:
- Publication type:
- Article
Identification of a WT1 protein-derived peptide, WT1<sub>187</sub>, as a HLA-A*0206-restricted, WT1-specific CTL epitope.
- Published in:
- Microbiology & Immunology, 2008, v. 52, n. 11, p. 551, doi. 10.1111/j.1348-0421.2008.00069.x
- By:
- Publication type:
- Article
WT1 peptide immunotherapy for gynecologic malignancies resistant to conventional therapies: a phase II trial.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 3, p. 457, doi. 10.1007/s00432-012-1348-2
- By:
- Publication type:
- Article
A Phase I/II Trial of a WT1 (Wilms' Tumor Gene) Peptide Vaccine in Patients with Solid Malignancy: Safety Assessment Based on the Phase I Data.
- Published in:
- Japanese Journal of Clinical Oncology, 2006, v. 36, n. 4, p. 231, doi. 10.1093/jjco/hyl005
- By:
- Publication type:
- Article
Wilms tumor gene WT1 peptide-based immunotherapy induced a minimal response in a patient with advanced therapy-resistant multiple myeloma.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Clinical and immunologic responses to very low-dose vaccination with WT1 peptide (5 microg/body) in a patient with chronic myelomonocytic leukemia.
- Published in:
- 2007
- By:
- Publication type:
- journal article
WT1 peptide‐based immunotherapy for advanced thymic epithelial malignancies.
- Published in:
- International Journal of Cancer, 2018, v. 142, n. 11, p. 2375, doi. 10.1002/ijc.31253
- By:
- Publication type:
- Article
WT1 IgG antibody for early detection of nonsmall cell lung cancer and as its prognostic factor.
- Published in:
- International Journal of Cancer, 2009, v. 125, n. 2, p. 381, doi. 10.1002/ijc.24367
- By:
- Publication type:
- Article
High frequencies of less differentiated and more proliferative WT1-specific CD8<sup>+</sup> T cells in bone marrow in tumor-bearing patients: An important role of bone marrow as a secondary lymphoid organ.
- Published in:
- Cancer Science, 2010, v. 101, n. 4, p. 848, doi. 10.1111/j.1349-7006.2009.01468.x
- By:
- Publication type:
- Article
Biased usage of BV gene families of T-cell receptors of WT1 (Wilms’ tumor gene)-specific CD8<sup>+</sup> T cells in patients with myeloid malignancies.
- Published in:
- Cancer Science, 2010, v. 101, n. 3, p. 594, doi. 10.1111/j.1349-7006.2009.01453.x
- By:
- Publication type:
- Article
Wilms’ tumor gene WT1 17AA(–)/KTS(–) isoform induces morphological changes and promotes cell migration and invasion in vitro.
- Published in:
- Cancer Science, 2006, v. 97, n. 4, p. 259, doi. 10.1111/j.1349-7006.2006.00169.x
- By:
- Publication type:
- Article
Overexpression of the Wilms' tumor gene WT1 in primary astrocytic tumors.
- Published in:
- Cancer Science, 2004, v. 95, n. 10, p. 822, doi. 10.1111/j.1349-7006.2004.tb02188.x
- By:
- Publication type:
- Article